To better understand the contribution of signaling triggered by EphB4 and ephrinB2 on tumor growth, we generated HNSCC cells expressing dominant-negative constructs of EphB4 and ephrinB2. The gene discussed is EFNB2; the disease is head and neck squamous cell carcinoma.